To further demonstrate whether the Ago2 is involved in Trp/miR‐193a‐3p mediated inhibition of CT26 tumor cell growth, the Ago2 inhibitor BCI‐137 (Sigma) was used to pretreat the CT26 cells. The gene discussed is AGO2; the disease is neoplasm.